Aia Group LTD Neurocrine Biosciences Inc Transaction History

Aia Group LTD

  • $3.67 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023
SELL
$94.11 - $123.02 $30,021 - $39,243
-319 Reduced 13.16%
2,105 $213,000
Q4 2022

Jan 31, 2023
BUY
$106.72 - $127.06 $258,689 - $307,993
2,424 New
2,424 $289,000
Q2 2022

Aug 11, 2022
BUY
$75.79 - $100.07 $124,295 - $164,114
1,640 New
1,640 $160,000

Others Institutions Holding NBIX

# of Institutions
625
Shares Held
94.2M
Call Options Held
632K
Put Options Held
621K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Aia Group LTD Portfolio

Follow Aia Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aia Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Aia Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email